Gabrielle Emanuel from Boston's NPR Station, WBUR, covers OpenBiome's launch of the FMT Capsule G3 - the first publicly available poop pill used to treat C. difficile infection. Here's an excerpt from the article:
"OpenBiome, the nation’s first stool bank, is beginning large-scale production of a poop pill. This week marks the first time such a pill will be commercially available to hospitals and clinics.
Early tests suggest the pill is highly effective and comparable to traditional, more invasive delivery methods — for instance via colonoscopy, enema or a plastic tube through the nose and into the stomach or intestines.
'Fecal transplants came from what used to be this dark art — where you needed a donor and a blender,” says Mark Smith, research director at OpenBiome and one of its founders. “And now you basically take something out of the freezer and can treat the patient immediately. I’m very, very excited about this.'"
Click here for the full article.